
The episode discusses advancements in psoriasis care through the use of oral IL-23 inhibitors.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/WNB865. CME/AAPA credit will be available until April 21, 2027. A New Era in Psoriasis Care With Oral IL-23 Inhibitors In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Support This activity is supported by an educational grant from Johnson & Johnson. Disclosure information is available at the beginning of the video presentation.
Guest: April W. Armstrong, MD, MPH
Johnson & Johnson
Organizations: PeerView Institute for Medical Education, Accreditation Council for Continuing Medical Education, Accreditation Council for Pharmacy Education, American Nurses Credentialing Center
Explore listener stats, chart rankings, contacts and more on the PeerView Immunology & Transplantation CME/CNE/CPE Video Podcast podcast page.